Castle Biosciences Inc
NASDAQ:CSTL

Watchlist Manager
Castle Biosciences Inc Logo
Castle Biosciences Inc
NASDAQ:CSTL
Watchlist
Price: 30.83 USD -3.05% Market Closed
Market Cap: 855.2m USD
Have any thoughts about
Castle Biosciences Inc?
Write Note

Castle Biosciences Inc
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Castle Biosciences Inc
Total Current Assets Peer Comparison

Comparables:
DVA
DGX
CVS
CI
LH

Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Castle Biosciences Inc
NASDAQ:CSTL
Total Current Assets
$344.8m
CAGR 3-Years
-4%
CAGR 5-Years
26%
CAGR 10-Years
N/A
DaVita Inc
NYSE:DVA
Total Current Assets
$4B
CAGR 3-Years
2%
CAGR 5-Years
0%
CAGR 10-Years
0%
Quest Diagnostics Inc
NYSE:DGX
Total Current Assets
$2.6B
CAGR 3-Years
-3%
CAGR 5-Years
8%
CAGR 10-Years
5%
CVS Health Corp
NYSE:CVS
Total Current Assets
$67.3B
CAGR 3-Years
3%
CAGR 5-Years
7%
CAGR 10-Years
10%
Cigna Corp
NYSE:CI
Total Current Assets
$49.2B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Laboratory Corporation of America Holdings
NYSE:LH
Total Current Assets
$4.9B
CAGR 3-Years
-7%
CAGR 5-Years
10%
CAGR 10-Years
11%

See Also

What is Castle Biosciences Inc's Total Current Assets?
Total Current Assets
344.8m USD

Based on the financial report for Sep 30, 2024, Castle Biosciences Inc's Total Current Assets amounts to 344.8m USD.

What is Castle Biosciences Inc's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
26%

Over the last year, the Total Current Assets growth was 23%. The average annual Total Current Assets growth rates for Castle Biosciences Inc have been -4% over the past three years , 26% over the past five years .

Back to Top